544 related articles for article (PubMed ID: 34122418)
1. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
Dudek AM; Porteus MH
Front Immunol; 2021; 12():660302. PubMed ID: 34122418
[TBL] [Abstract][Full Text] [Related]
2. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Brault J; Liu T; Liu S; Lawson A; Choi U; Kozhushko N; Bzhilyanskaya V; Pavel-Dinu M; Meis RJ; Eckhaus MA; Burkett SS; Bosticardo M; Kleinstiver BP; Notarangelo LD; Lazzarotto CR; Tsai SQ; Wu X; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Front Immunol; 2022; 13():1067417. PubMed ID: 36685559
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
Bak RO; Porteus MH
Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
[TBL] [Abstract][Full Text] [Related]
5. Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.
Schiroli G; Conti A; Ferrari S; Della Volpe L; Jacob A; Albano L; Beretta S; Calabria A; Vavassori V; Gasparini P; Salataj E; Ndiaye-Lobry D; Brombin C; Chaumeil J; Montini E; Merelli I; Genovese P; Naldini L; Di Micco R
Cell Stem Cell; 2019 Apr; 24(4):551-565.e8. PubMed ID: 30905619
[TBL] [Abstract][Full Text] [Related]
6. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
Hiramoto T; Li LB; Funk SE; Hirata RK; Russell DW
Mol Ther; 2018 May; 26(5):1255-1265. PubMed ID: 29606506
[TBL] [Abstract][Full Text] [Related]
7. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing.
Ling C; Bhukhai K; Yin Z; Tan M; Yoder MC; Leboulch P; Payen E; Srivastava A
Sci Rep; 2016 Oct; 6():35495. PubMed ID: 27759036
[TBL] [Abstract][Full Text] [Related]
8. Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.
Ferrari S; Jacob A; Cesana D; Laugel M; Beretta S; Varesi A; Unali G; Conti A; Canarutto D; Albano L; Calabria A; Vavassori V; Cipriani C; Castiello MC; Esposito S; Brombin C; Cugnata F; Adjali O; Ayuso E; Merelli I; Villa A; Di Micco R; Kajaste-Rudnitski A; Montini E; Penaud-Budloo M; Naldini L
Cell Stem Cell; 2022 Oct; 29(10):1428-1444.e9. PubMed ID: 36206730
[TBL] [Abstract][Full Text] [Related]
9. AAV Vectorization of DSB-mediated Gene Editing Technologies.
Moser RJ; Hirsch ML
Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
[TBL] [Abstract][Full Text] [Related]
10. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
11. Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction.
Shao W; Earley LF; Chai Z; Chen X; Sun J; He T; Deng M; Hirsch ML; Ting J; Samulski RJ; Li C
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925692
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to adeno-associated virus vectors.
Zaiss AK; Muruve DA
Curr Gene Ther; 2005 Jun; 5(3):323-31. PubMed ID: 15975009
[TBL] [Abstract][Full Text] [Related]
13. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
Grimm D; Büning H
Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
[TBL] [Abstract][Full Text] [Related]
14. Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex.
de Alencastro G; Puzzo F; Pavel-Dinu M; Zhang F; Pillay S; Majzoub K; Tiffany M; Jang H; Sheikali A; Cromer MK; Meetei R; Carette JE; Porteus MH; Pekrun K; Kay MA
Mol Ther; 2021 Mar; 29(3):1016-1027. PubMed ID: 33678249
[TBL] [Abstract][Full Text] [Related]
15. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional AAV-CRISPR-Cas9 and its host response.
Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
[TBL] [Abstract][Full Text] [Related]
17. Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.
Moreno AM; Palmer N; Alemán F; Chen G; Pla A; Jiang N; Leong Chew W; Law M; Mali P
Nat Biomed Eng; 2019 Oct; 3(10):806-816. PubMed ID: 31332341
[TBL] [Abstract][Full Text] [Related]
18. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
19. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
Verdera HC; Kuranda K; Mingozzi F
Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133
[TBL] [Abstract][Full Text] [Related]
20. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
Lee BC; Lozano RJ; Dunbar CE
Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
